Clomid (Clomiphene)

When Clomid may be considered

Clomiphene can be considered when a person who wants to become pregnant has ovulatory dysfunction and is otherwise suitable for treatment. It is not a general fertility booster and does not correct every reason pregnancy has not occurred. Blocked tubes, sperm-related factors and other conditions may require a different approach.

We discuss whether ovulation is absent, irregular or already occurring. Menstrual dates alone do not always answer that question. Your history, hormone results and ultrasound findings may help establish what is happening and whether clomiphene is likely to be useful. A clear diagnosis makes the treatment more purposeful.

For some conditions, including particular cases of polycystic ovary syndrome, another medicine may be preferred. We review the available options in the context of your health and specialist recommendations. Choosing a familiar brand should not take precedence over a treatment that better fits your diagnosis and pregnancy plans.

Assessment before starting a cycle

Bring menstrual dates, pregnancy history, previous fertility treatments and results from hormone tests or scans. We ask how long you have been trying to conceive, whether cycles are predictable and whether there is pain, abnormal bleeding or a history of pelvic infection. These details help determine which investigations are needed before treatment.

Pregnancy must be excluded before a new cycle. We also review ovarian cysts or enlargement, unexplained uterine bleeding, liver disease and conditions involving the thyroid or adrenal glands. Some findings make clomiphene unsuitable or require treatment first. Starting tablets before these issues are clarified can delay more appropriate care.

Fertility assessment may involve your partner or the person providing sperm as well as evaluation of the fallopian tubes. We explain which parts are relevant to you. Ovulation induction should not become repeated treatment while another important reason for infertility remains unassessed. Bring previous reports so care can build on work already completed.

Clomid price and medication purchase

The medication cost depends on the prescribed product and quantity. A pack size is not the same as a treatment cycle, because the number of tablets used depends on the dose and the agreed schedule. We confirm the prescription and medication charge after reviewing the cycle plan and monitoring arrangements.

For a market comparison, discounted pharmacy listings for generic clomiphene 50 mg show approximately $69.28 for 10 tablets or $187.85 for 30 tablets. A published branded Clomid 50 mg listing is approximately $437.60 for 30 tablets. These are medication examples, not the total cost of fertility care.

Retail prices are estimates and may change frequently. Consultations, ultrasound scans, laboratory tests and other fertility services are separate from medication purchase. A larger pack should not be used to start additional cycles without the assessment and instructions required for each one.

Your treatment cycle and dose

Clomiphene is taken for a short part of a planned cycle, not continuously every day throughout the month. A common initial regimen is 50 mg daily for five days, but the timing and suitability are decided by the treating clinician. This description is not an instruction to start a cycle yourself.

We explain when to begin, how to record the doses and when assessment or testing is due. If the first course does not produce ovulation, a later adjustment may be considered after reviewing the response. Do not extend a course, repeat it early or increase the dose without that review.

If a dose is missed or vomited, contact the fertility team for advice. The timing of a short course matters, and taking extra tablets to catch up may not be appropriate. Keep the labeled pack and written schedule together so that the tablet strength, cycle dates and instructions are easy to check.

Monitoring ovulation and response

Your monitoring plan may include ultrasound and hormone testing to assess follicle development and whether ovulation occurred. The approach depends on your diagnosis, previous response and the fertility service involved. We make sure you know what will be checked and who will review the results before treatment begins.

Ovulation predictor tests can be helpful in some circumstances, but their interpretation is not always straightforward, particularly with irregular cycles or PCOS. A positive home test is not a substitute for all clinical monitoring. Tell us what tests you use and bring the results alongside your cycle record.

Timing intercourse or an insemination procedure should follow your individual fertility plan. Clomiphene cannot guarantee fertilization, implantation or a live birth. If ovulation occurs without pregnancy, we review the wider picture rather than assume that repeatedly increasing the dose will improve the chance of success.

Ovarian enlargement and multiple pregnancy

Clomiphene can stimulate more than one follicle and increases the chance of a multiple pregnancy. We discuss that possibility before treatment, including the additional pregnancy risks associated with twins or higher-order multiples. Monitoring helps guide decisions about whether a cycle should proceed and what precautions are needed.

Ovarian enlargement can cause pelvic discomfort or bloating. More severe pain, rapid abdominal swelling, vomiting, breathlessness, reduced urine or a rapid increase in weight needs urgent assessment. Ovarian hyperstimulation is an important concern even though severe cases are less common with clomiphene than with some injectable fertility treatments.

An enlarged ovary can also be vulnerable to twisting, which may present as sudden severe one-sided pain. Do not dismiss a significant change as a normal part of ovulation. Contact the treating team promptly, and seek emergency care when pain or associated symptoms are severe.

Vision and other side effects

Hot flushes, headache, nausea, breast discomfort and mood changes can occur during treatment. Tell us if they are persistent or disruptive. We can review the severity, the timing within the cycle and whether another treatment is more suitable. Do not simply increase or continue tablets because a course is nearly finished.

Visual symptoms deserve a different response. Blurring, spots, flashes or difficulty seeing should lead to stopping clomiphene and prompt medical review, including an eye assessment when needed. Avoid driving or activities where impaired vision would be dangerous. Symptoms should be reported even if they seem brief or painless.

Tell us about previous visual problems during a clomiphene course before considering another cycle. Persistent symptoms can occur, so restarting should not be a trial-and-error decision. A severe headache accompanied by visual loss, weakness or other neurological symptoms needs urgent assessment for causes beyond a medicine side effect.

Pregnancy, other medicines and special situations

Clomiphene must not be used during pregnancy. Test as instructed before another course and tell the fertility team if bleeding is late or unusual. A positive pregnancy test changes the next steps. Pain, dizziness or bleeding in early pregnancy requires prompt assessment, including consideration of an ectopic pregnancy.

Give us a list of hormones, fertility medicines, supplements and other prescriptions. Combining treatments can alter the response and monitoring needed. Products marketed as fertility supplements are not automatically appropriate alongside a prescription cycle. Let us review the ingredients rather than assume that an over-the-counter product cannot affect treatment.

Clomiphene is also used off label in selected male fertility or hormone conditions under specialist care. That is a separate indication with different assessment and follow-up. Do not use a partner's ovulation treatment for testosterone or sperm concerns. We can discuss the right reproductive or andrology assessment for that situation.

Reviewing further cycles

Treatment is limited and reassessed rather than continued indefinitely. The number of cycles, response and any reason to stop are decided with the fertility clinician. If ovulation has not occurred or pregnancy has not followed an appropriate trial, further investigation or another treatment may offer a better next step.

At review, bring cycle dates, tablet use, test results and any side effects. Tell us about changes in bleeding, pelvic pain or vision before requesting another supply. We check that pregnancy and ovarian concerns have been addressed and that the next cycle still fits the overall fertility plan.

We can use an online consultation to review records and discuss treatment, but scans, examinations and laboratory testing may need to take place in person. Medication purchase follows the prescribing decision. The aim is coordinated fertility care with clear ownership of the monitoring, not tablets supplied without the support needed to use them safely.

Keeping the fertility plan coordinated

If scans, laboratory tests and prescribing take place at different services, make sure the results reach the clinician directing the cycle. A scan report without the cycle date or recent dose can be difficult to interpret. Keep the treatment schedule and relevant reports together and bring them to each review.

Tell the team if a planned scan or test cannot be completed before starting tablets. The response may be to rearrange the cycle rather than proceed without the information needed. This avoids uncertainty about who is monitoring the response and whether another course is suitable.

Fertility treatment can be emotionally demanding. Discuss the burden of timed treatment, repeated tests or an unsuccessful cycle as well as physical side effects. We can help identify support and a suitable next discussion with your fertility clinician rather than make the next prescription the only focus of care.

Common questions